Navigating 4 Analyst Ratings For Evolent Health
Navigating 4 Analyst Ratings For Evolent Health
浏览 Evolent Health 的 4 个分析师评级
In the preceding three months, 4 analysts have released ratings for Evolent Health (NYSE:EVH), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有4位分析师发布了Evolent Health（纽约证券交易所代码：EVH）的评级，提出了从看涨到看跌的各种观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表总结了他们最近的评估，说明了过去30天不断变化的情绪，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Evolent Health, revealing an average target of $45.0, a high estimate of $52.00, and a low estimate of $38.00. A 1.47% drop is evident in the current average compared to the previous average price target of $45.67.
分析师已经为Evolent Health设定了12个月的目标股价，显示平均目标股价为45.0美元，最高估计为52.00美元，低估值为38.00美元。与之前的平均目标价45.67美元相比，当前的平均价格下降了1.47％。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：仔细观察
The perception of Evolent Health by financial experts is...
通过分析师最近的行...
登录免费看全文
登录/注册